Fibrinolytic agents.
D000614:Aminocaproates / Q000008:administration & dosage; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism / Q000502:physiology; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D009539:Nicotinic Acids / Q000008:administration & dosage; D010447:Peptide Hydrolases / Q000627:therapeutic use; D010958:Plasminogen / Q000378:metabolism / Q000502:physiology; D011655:Pulmonary Embolism / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D013924:Thrombophlebitis / Q000139:chemically induced; D013927:Thrombosis / Q000188:drug therapy; D014357:Trypsin / Q000009:adverse effects
D000614:Aminocaproates; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D010447:Peptide Hydrolases; D014357:Trypsin; D005341:Fibrinolysin